Homsun Capital is an investment firm.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 11, 2020
Asieris Pharmaceuticals
|
Series D | ¥700M | Biotechnology | — |
Mar 7, 2017
ChoiPharm
|
Angel | ¥3M | Biotechnology | — |
Feb 22, 2017
CHOITEC
|
Angel | ¥3M | Health Care | — |
Jun 24, 2016
Tianzhi Hulian
|
Series B | ¥20M | Information Technology | — |
Oct 28, 2011
L'AVION
|
Series A | ¥10M | Health Care | Yes |
Homsun Capital has had 2 exits. Homsun Capital most notable exits include Asieris Pharmaceuticals , Tianzhi Hulian
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Jan 7, 2022 | Asieris Pharmaceuticals | IPO | Biotechnology | Detail |
May 2, 2017 | Tianzhi Hulian | IPO | Information Technology | Detail |